Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Medela Potentia Tbk. (MDLA) Price & Performance

UBC Medical Indonesia Tbk.Trade
Medela Potentia Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Medela Potentia Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Medela Potentia Tbk. trades at Rp208 (market cap 2.89T, 269K 24h volume). The key difference: Medela Potentia Tbk. is far larger — about 5× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.48M versus 269K). Which is the better fit depends on your goals.

LABSMDLA
Market Cap
576.7B2.89T
Volume
3.48M269K
Lot
34.82K2.69K
Turnover
522.79M55.76M
Average Price
150.13207.28
Value
522.79M55.76M
Indicative Equilibrium Price
148208
Indicative Equilibrium Volume
35015

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
MDLA
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Medela Potentia Tbk.

PT Medela Potentia Tbk. (Company) was established based on Deed of Establishment No. 04 dated August 5, 2011, of Public Notary Evy Ferdiana, S.H, Notary of Bekasi Regency, domiciled in Lemah Abang. The Company started its operation activities in 2013.

Read more on MDLA